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Abstract
Background
Long-lasting insecticidal nets (LLINs) and indoor residual spraying of insecticide (IRS) are
the primary vector control interventions used to prevent malaria in Africa. Although both
interventions are effective in some settings, high-quality evidence is rarely available to eval-
uate their effectiveness following deployment by a national malaria control program. In
Uganda, we measured changes in key malaria indicators following universal LLIN distribu-
tion in three sites, with the addition of IRS at one of these sites.
Methods and Findings
Comprehensive malaria surveillance was conducted from October 1, 2011, to March 31,
2016, in three sub-counties with relatively low (Walukuba), moderate (Kihihi), and high
transmission (Nagongera). Between 2013 and 2014, universal LLIN distribution campaigns
were conducted in all sites, and in December 2014, IRS with the carbamate bendiocarb
was initiated in Nagongera. High-quality surveillance evaluated malaria metrics and mos-
quito exposure before and after interventions through (a) enhanced health-facility-based
surveillance to estimate malaria test positivity rate (TPR), expressed as the number testing
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positive for malaria/number tested for malaria (number of children tested for malaria: Walu-
kuba = 42,833, Kihihi = 28,790, and Nagongera = 38,690); (b) cohort studies to estimate
the incidence of malaria, expressed as the number of episodes per person-year [PPY] at
risk (number of children observed: Walukuba = 340, Kihihi = 380, and Nagongera = 361);
and (c) entomology surveys to estimate household-level human biting rate (HBR),
expressed as the number of female Anopheles mosquitoes collected per house-night of
collection (number of households observed: Walukuba = 117, Kihihi = 107, and Nagongera
= 107). The LLIN distribution campaign substantially increased LLIN coverage levels at the
three sites to between 65.0% and 95.5% of households with at least one LLIN. In Walu-
kuba, over the 28-mo post-intervention period, universal LLIN distribution was associated
with no change in the incidence of malaria (0.39 episodes PPY pre-intervention versus 0.20
post-intervention; adjusted rate ratio [aRR] = 1.02, 95% CI 0.36–2.91, p = 0.97) and non-
significant reductions in the TPR (26.5% pre-intervention versus 26.2% post-intervention;
aRR = 0.70, 95% CI 0.46–1.06, p = 0.09) and HBR (1.07 mosquitoes per house-night pre-
intervention versus 0.71 post-intervention; aRR = 0.41, 95% CI 0.14–1.18, p = 0.10). In
Kihihi, over the 21-mo post-intervention period, universal LLIN distribution was associated
with a reduction in the incidence of malaria (1.77 pre-intervention versus 1.89 post-inter-
vention; aRR = 0.65, 95% CI 0.43–0.98, p = 0.04) but no significant change in the TPR
(49.3% pre-intervention versus 45.9% post-intervention; aRR = 0.83, 95% 0.58–1.18,
p = 0.30) or HBR (4.06 pre-intervention versus 2.44 post-intervention; aRR = 0.71, 95% CI
0.30–1.64, p = 0.40). In Nagongera, over the 12-mo post-intervention period, universal
LLIN distribution was associated with a reduction in the TPR (45.3% pre-intervention ver-
sus 36.5% post-intervention; aRR = 0.82, 95% CI 0.76–0.88, p < 0.001) but no significant
change in the incidence of malaria (2.82 pre-intervention versus 3.28 post-intervention;
aRR = 1.10, 95% 0.76–1.59, p = 0.60) or HBR (41.04 pre-intervention versus 20.15 post-
intervention; aRR = 0.87, 95% CI 0.31–2.47, p = 0.80). The addition of three rounds of IRS
at ~6-mo intervals in Nagongera was followed by clear decreases in all outcomes: inci-
dence of malaria (3.25 pre-intervention versus 0.63 post-intervention; aRR = 0.13, 95% CI
0.07–0.27, p < 0.001), TPR (37.8% pre-intervention versus 15.0% post-intervention; aRR =
0.54, 95% CI 0.49–0.60, p < 0.001), and HBR (18.71 pre-intervention versus 3.23 post-
intervention; aRR = 0.29, 95% CI 0.17–0.50, p < 0.001). High levels of pyrethroid resistance
were documented at all three study sites. Limitations of the study included the observa-
tional study design, the lack of contemporaneous control groups, and that the interventions
were implemented under programmatic conditions.
Conclusions
Universal distribution of LLINs at three sites with varying transmission intensity was associ-
ated with modest declines in the burden of malaria for some indicators, but the addition of
IRS at the highest transmission site was associated with a marked decline in the burden of
malaria for all indicators. In highly endemic areas of Africa with widespread pyrethroid resis-
tance, IRS using alternative insecticide formulations may be needed to achieve substantial
gains in malaria control.
Malaria Burden following Control Interventions in Uganda
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Author Summary
Why Was This Study Done?
• Long-lasting insecticidal nets (LLINs), which prevent mosquitoes from biting people
while they sleep, and indoor residual spraying of insecticides (IRS) in houses, which pre-
vents mosquitoes from resting in houses, are the main tools used to prevent malaria in
Africa.
• Although LLINs and IRS have been shown to be effective, changes in the behavior of
mosquitoes and people as well as the emergence of mosquitoes resistant to insecticides
could compromise the benefits of these interventions.
• Recently the government of Uganda distributed free LLINs throughout the country and
began IRS in selected areas. In this “real world” setting, it is important to monitor for
changes in the burden of malaria following the scale-up of LLIN distribution and IRS.
What Did the Researchers Do and Find?
• The researchers conducted comprehensive malaria surveillance betweenOctober 1,
2011, and March 31, 2016, at three sites in Uganda that differed in the intensity of
malaria transmission.
• Between 2013 and 2014, LLINs were distributed to the entire population at all three
sites, and in December 2014, IRS with an insecticide different from that used in the
LLINs was started in the site with the highest level of malaria transmission.
• The researchers found that following LLIN distribution, there were only modest
declines in some measures of malaria burden at the three sites, and no changes in other
measures.
• In contrast, following the addition of IRS at the highest transmission site, all measures of
malaria burden declined dramatically.
• The research also documented a high level of resistance to the type of insecticide used in
LLINS at all three sites.
What Do These Findings Mean?
• These findings suggest that in countries like Uganda, which has a heavy burden of
malaria, LLINs alone may not be adequate to substantially drive down the burden of
malaria, and the addition of IRS using a different insecticidemay be needed to have a
major impact.
• However, it should be noted that IRS is more expensive and harder to implement than
distributing LLINs, and generally needs to be repeated every 6–12 months to have a sus-
tained effect.
Malaria Burden following Control Interventions in Uganda
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Introduction
Over the last fifteen years, funding for malaria control activities has increased dramatically
across Africa, leading to the scale-up of proven interventions including distribution of long-
lasting insecticidal nets (LLINs), indoor residual spraying of insecticide (IRS), and treatment of
malaria cases with artemisinin-basedcombination therapy (ACT) [1]. Substantial declines in
measures of malaria burden have been attributed to the expansion of these interventions at var-
ious scales, from the sub-national level to the entire continent [2–4]. Despite these advances,
the burden of malaria remains high, with an estimated 215 million cases and 438,000 deaths
worldwide in 2015, of which 88% of cases and 90% of deaths were in Africa [1].
LLINs have been shown to reduce malaria morbidity and mortality across a range of
epidemiological settings, and the World Health Organization (WHO) recommends
universal coverage of populations at risk [5,6]. IRS has also been shown to be highly effective,
but it is more resource-intensive and expensive to implement than distribution of LLINs
[7,8]. Historically, IRS played a key role in the global malaria elimination campaign in the
1950s and 1960s, but was not widely used in sub-Saharan Africa primarily due to limited
resources [9]. More recently, the use of IRS in sub-Saharan Africa has been expanded from
epidemic-prone areas with seasonal transmission to areas with more intense perennial trans-
mission [10]. However, despite the widespread use of LLINs and IRS, and the importance of
quantifying the impact of malaria control interventions in operational settings, high-quality
contemporary data are limited. This is largely due to a paucity of rigorous longitudinal
malaria surveillance studies that can capture the impact of interventions over time. Indeed,
most estimates of the impact of population-level malaria control interventions rely on
health facility records, which are often incomplete and/or inaccurate, or repeated cross-sec-
tional surveys that measure parasite prevalence, which provides only an indirect estimate of
morbidity.
We report findings from a comprehensive malaria surveillanceprogram conducted in three
areas of Uganda with varied transmission intensities from October 2011 to March 2016, a
period of major expansion in population-level malaria control interventions. Uganda has
reported some of the highest levels of transmission intensity and ranks fourth globally in the
estimated number of annual cases of malaria [1,11]. Given that malaria is endemic in over 95%
of the country and the burden remains high in many areas, efforts have focused on control and
not elimination [12]. From 2012 to 2014, Uganda implemented a national universal LLIN dis-
tribution campaign, with 21 million LLINs distributed to a population of approximately 35
million people [13]. In December 2014, IRS was implemented for the first time in one of our
three study areas. Evaluations included enhanced health-facility-based surveillance to estimate
malaria test positivity rate (TPR), cohort studies to estimate the incidence of malaria, entomol-
ogy surveys to estimate transmission intensity, insecticide susceptibility testing, and repeated
cross-sectional community surveys to estimate the coverage level of key malaria control
interventions.
Methods
Ethics Statement
Ethical approval was obtained from the Makerere University School of Medicine Research and
Ethics Committee, the Uganda National Council for Science and Technology, the London
School of Hygiene & Tropical Medicine Ethics Committee, the DurhamUniversity School of
Biological and Biomedical Sciences Ethics Committee, and the University of California, San
Francisco, Committee on Human Research.
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Study Sites
Comprehensive surveillance studies were conducted in three sub-counties in Uganda: Walu-
kuba, Jinja District; Kihihi, Kanungu District, and Nagongera, Tororo District (Fig 1). These
areas were chosen to represent variedmalaria transmission settings.Walukuba is a relatively
low transmission, peri-urban area near Lake Victoria in the south-central part of the country.
Kihihi is a rural area with moderate transmission intensity bordering a national park in the
southwestern part of the country. Nagongera is a rural area with high transmission intensity in
the southeastern part of the country near to the border with Kenya (Fig 1). Transmission in all
of these areas is perennial, with two annual peaks following the rainy seasons.
Health-Facility-Based Surveillance
Enhancedmalaria surveillancewas conducted at one government-run level IV health center at
each study site, as describedpreviously [15]. Briefly, individual-level data on all patients pre-
senting to the outpatient department of the facilities were collected electronically using a stan-
dardized data collection form. Data collected included patient age, whether symptomatic
malaria was suspected (as determined by the evaluating clinician), whether laboratory testing
for malaria was done, the type of laboratory testing done (either light microscopy or rapid
diagnostic test), and the results of the laboratory test. Study staff visited the health facilities
periodically to provide training and feedback including quality control of diagnostic testing.
Enhanced surveillancewas begun in 2006, but this report only includes data fromOctober 1,
2011, to March 31, 2016, when data became available from the other malaria surveillance stud-
ies described below.
Cohort Studies
Cohort studies were performed in children from households randomly selected from enumera-
tion surveys conducted in each of the three sub-counties, as previously described [16]. Briefly,
all eligible children aged 0.5–10 y were enrolled from 100 households from each study site
betweenAugust and September 2011. The cohorts were dynamic, such that all newly eligible
children were enrolled during follow-up and study participants who reached 11 y of age were
excluded from further follow-up. At enrolment, written informed consent was provided by
parents/guardians and study participants were given an LLIN and underwent a standardized
evaluation. Cohort study participants received all medical care free of charge at designated
study clinics open every day. Parents/guardians were encouraged to bring their children to the
clinic any time they were ill and were reimbursed for transport costs. Children who presented
with a documented fever (tympanic temperature 38.0°C) or history of fever in the previous
24 h had blood obtained by finger prick for a thick blood smear. If the smear was positive for
malaria parasites, the patient was diagnosedwith malaria. Episodes of uncomplicated malaria
were treated with artemether-lumefantrine, and episodes of complicated malaria or recurrent
malaria occurringwithin 14 d of prior therapy were treated with quinine. Study participants
were withdrawn from the study for (a) permanent movement out of the sub-county, (b) inabil-
ity to be located for>4 mo, (c) withdrawal of informed consent, (d) inability to comply with
the study schedule and procedures, or (e) reaching 11 y of age. Children from 31 randomly
selected additional households were enrolled betweenAugust and October 2013 to replace
households in which all study participants had been withdrawn and were followed using the
same procedures described above. A full description of the selection of study households and
participants is provided in S1 Fig.
Malaria Burden following Control Interventions in Uganda
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Fig 1. Map of Uganda showing study sites. Parasite prevalence in children 2–10 y of age from cross-sectional surveys
conducted in 2012: Walukuba = 16%; Kihihi = 18%; Nagongera = 60% [14].
doi:10.1371/journal.pmed.1002167.g001
Malaria Burden following Control Interventions in Uganda
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Entomology Surveys
For each household participating in the cohort studies, entomological surveys were performed,
as describedpreviously [16,17]. Briefly, mosquitoes were collected once a month from each
cohort study household using miniature CDC light traps (Model 512; John W. Hock Com-
pany) with the light positioned 1 m above the floor at the foot end of the bed where a cohort
study participant slept. Traps were set at 19.00 h and collected at 07.00 h the followingmorning
by field workers. Female Anopheles mosquitoes were identified taxonomically to species level
based on morphological criteria according to established taxonomic keys [18]. Members of the
A. gambiae complex were identified by PCR [19] for 30 mosquitoes randomly selected at each
site each month. Sporozoites were identified in individual mosquitoes stored with desiccant
using an ELISA technique [20]. All femaleAnopheles mosquitoes captured inWalukuba and
Kihihi were tested for sporozoites. Due to the large numbers of female Anopheles mosquitoes
captured in Nagongera, only up to 50 randomly selectedmosquitoes per household per night
of collectionwere tested for sporozoites.
Cross-sectional Community Surveys
Annual cross-sectional surveyswere conducted in each of the study sites in 2012, 2013, and
2015, as previously described [14]. Briefly, for each survey, households were randomly selected
from our enumeration list and sequentially screened until 200 households were enrolled. The
purpose of the study was discussedwith the head of the household or their designate, and con-
sent to participate in the surveywas sought. Households with no adult respondent during the
initial contact were revisited up to three times before excluding them from the sample selection.
After obtaining written informed consent, a household questionnaire was administered to the
head of the household or their designate. The questionnaire was used to capture information
on the demographics of all household members and the use of malaria prevention methods.
The surveys were conducted over the same 2-mo period each year in each of three sub-coun-
ties:Walukuba, Jinja District (March–April); Kihihi, Kanungu District (May–June); and
Nagongera, Tororo District (January–February).
Population-Level Malaria Control Interventions
Prior to 2012, a number of sub-national LLIN distribution campaigns were carried out in
Uganda. From September 2012 through August 2014, the government of Uganda carried out a
countrywidemass distribution of free LLINs. An estimated 21 million LLINs were distributed,
with the goal of achieving universal coverage with at least one LLIN for every two people. For
our study sites, LLINs were distributed during November 2013 in Jinja and Tororo Districts,
which includedWalukuba and Nagongera, and during June 2014 in Kanungu District, which
included Kihihi. Data on the population at risk and the number of LLINs distributed at our
study sites were obtained from the Ugandan National Malaria Control Program (NMCP).
In 2006, Uganda initiated an IRS program, initially focusing on epidemic-prone areas in the
southwestern part of the country. In 2009, the IRS program was moved to ten northern districts
with high transmission intensity. In 2014–2015, the IRS program was moved to 14 districts in
the Lango, Bukedi, and Teso sub-regions located in the central and eastern part of the country
[13]. With respect to our study sites, Walukuba sub-county has not received IRS, and Kihihi
sub-county received a single round of IRS using the pyrethroid lambda-cyhalothrin in Febru-
ary–March 2007. In Tororo District, including Nagongera sub-county, the first round of IRS
using the carbamate bendiocarbwas delivered in December 2014–February 2015, a second
round in June–July 2015, and a third round in November–December 2015, with plans to
Malaria Burden following Control Interventions in Uganda
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continue IRS every 6 mo for at least 3 y. Data on the number of households targeted and the
number that received IRS in Nagongera were obtained from the Ugandan NMCP.
Measurement of Other Covariates of Interest
Estimates of monthly rainfall were obtained from the NASA Tropical RainfallMeasuringMis-
sion [21]. Insecticide susceptibility testing was conducted at the three study sites from January
to June 2014, as describedpreviously [22]. Briefly, mosquitoes were collected as larvae using
the dipping method from a variety of breeding sites. Larvaewere transferred to an insectary
and reared to adulthood. Emerging adults were fed on a 10% sugar solution and identified as
belonging to the A. gambiae species complex using morphological keys. Non-blood-fed female
mosquitoes (3–5 d old) were exposed to insecticide-treatedpapers impregnated withWHO
diagnostic concentrations (4% DDT, 0.05% deltamethrin, 0.75% permethrin, 0.1% bendiocarb,
1% fenitrothion, and 5%malathion). Batches of 20–25 mosquitoes were exposed to each insec-
ticide for 1 h, and mortality scored 24 h post-exposure in accordance with standard WHO
insecticide susceptibility testing procedures.
Statistical Analysis
One of the primary objectives of establishing our comprehensive malaria surveillance study
was to estimate the changes in measures of transmission intensity, infection, and disease using
surveillancedata at multiple sites in Uganda following the implementation of malaria control
measures (as described in S1–S4 Texts). It was originally anticipated that community-level
changes in the coverage of key malaria control interventions would be gradual. To make causal
inferences on the effect of these interventions, a counterfactual framework was originally
planned to estimate what the outcome variable of interest would be if the malaria control inter-
vention were set to a specific level. However, following the establishment of our comprehensive
malaria surveillance study, the Uganda NMCP rapidly implemented two major interventions
(universal LLIN distribution and IRS) covering our study sites. Given this opportunity, we
adjusted our analytical plan and performed the “before and after” comparisons described
below.
All data were collected using standardized data collection forms and entered using Micro-
soft Access. Analyses were performed using Stata version 14 (StataCorp) and R version 3.2.1
(https://www.r-project.org/). Data for all analyses describedbelow covered the period from
October 1, 2011, throughMarch 31, 2016. For health-facility-based surveillance, the primary
metric was the TPR, defined as the proportion of patients tested for malaria who tested positive
by microscopy or rapid diagnostic test. Data from health-facility-based surveillanceused in
this report only included children 0.5 to 10 y of age to mirror the age range included in the
cohort studies. For the cohort studies, the primarymetric was malaria incidence, defined as the
number of new episodes of malaria per person-year [PPY] of observation.New episodes of
malaria were defined as any episode of laboratory-confirmedmalaria not preceded by another
episode of malaria in the prior 14 d. For the entomology surveys, the primarymetric was the
daily human biting rate (HBR), defined as the total number of femaleAnopheles mosquitoes
captured per house-night of collection from the same households participating in the cohort
studies. Monthly time series were created for each of the three surveillancemethods. An LLIN
variable was created with time periods corresponding to the dates before and after the universal
distribution campaigns were completed at each study site (cutoff at December 1, 2013, for
Walukuba and Nagongera and July 1, 2014, for Kihihi). For Nagongera, an IRS variable was
created with time periods corresponding the dates after the LLIN distribution campaign
through 2 mo following the initiation of the first round of IRS (December 1, 2013–January 31,
Malaria Burden following Control Interventions in Uganda
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2015) and to 2 mo after the initiation of each subsequent round of IRS (cutoffs at February 1,
2015, August 1, 2015, and January 1, 2016). Autoregressive integrated moving average
(ARIMA)models were used and, specifically, the ARIMAX form of ARIMAmodels was used
for this study, which is a multivariate transfer functionmodel and includes current and/or past
values of independent variables as predictors [23]. ARIMAXmodels were developed to esti-
mate the adjusted rate ratios (aRRs) when comparing metrics before and after the interven-
tions. Potential confounders included in the models were age, gender, and rainfall at a 1-mo
lag. Seasonal terms were examined for each model, and candidate models were selected
through the inspection of residual autocorrelation diagnostics via the autocorrelation function,
the partial autocorrelation function, and the Ljung-Box test. The Akaike information criteria of
all candidate models were compared for selection of the final model. Additional details of the
ARIMAmodels used in the time-series analyses are provided in S1 Table. A p-value< 0.05 was
considered statistically significant.
This study provided the opportunity to evaluate relationships between temporal changes in
malaria incidencemeasured in the cohort studies and TPR measured by health-facility-based
surveillance.While a direct measure of malaria incidence is considered the gold standard for
estimating malaria morbidity, the TPR offers a surrogate measure [24]. Assuming that patients
undergoing laboratory testing for malaria at a health facility are representative of the catch-
ment population, the relationship between the TPR and the true incidence of malaria (Im) and
non-malarial fevers (Inm) for any time interval can be defined as follows:
TPR
1   TPR
¼
Im
Inm
From the cohort studies, the observed relative monthly change in the incidence of malaria
(observed rΔIm) was defined as Imi+1/Imi, where i represents the month of observation. For
the health-facility-based surveillance, rΔIm can be predicted from the TPR using the following
formula:
predicted rDIm ¼
Inmiþ1
Inmi

TPRiþ1ð1   TPRiÞ
TPRið1   TPRiþ1Þ
For health-facility-based surveillance, the incidence of non-malarial fevers in the catchment
populations was unknown. Therefore, estimates of the incidence of non-malarial fevers from
the cohort studies (defined as the number of new episodes of fever with a negative blood smear
PPY of observation)were used when calculating the predicted rΔIm. Relationships between rel-
ative monthly changes in the incidence of malaria observed from the cohort studies and those
predicted from health-facility-based surveillance (log transformed) were investigated using the
Pearson correlation coefficient.
Results
Health-facility-based surveillance involved a total of 110,313 outpatient visits among children
0.5 to 10 y of age from all three sites combined over the 4.5-y observation period (Table 1). The
proportion of visits for which malaria was suspected ranged from 54.9% to 82.4% across the
three sites. Over 98% of patients with suspectedmalaria underwent laboratory testing at all
three sites, and the TPR ranged from 26.4% inWalukuba to 48.4% in Kihihi. For the cohort
studies, a total of 1,081 children were observedover 3,258 person-years. A total of 5,213 epi-
sodes of malaria were diagnosed,with an incidence ranging from 0.29 episodes PPY inWalu-
kuba to 2.41 episodes PPY in Nagongera. Only 12 episodes of malaria (0.2% of total) met
criteria for severe malaria (5 severe anemia, 4 multiple convulsions, 2 cerebral malaria, and 1
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respiratory distress). There were no deaths due to malaria. Two children with negative blood
smears died of diarrheal illnesses.Monthly entomology surveyswere conducted in 331 house-
holds involving 15,206 nights of collection.A total of 155,613 femaleAnopheles mosquitoes
were collected, demonstrating daily HBRs ranging from 0.88 inWalukuba to 26.12 in Nagon-
gera and sporozoite rates ranging from 0.84% inWalukuba to 1.84% in Nagongera. Estimates
of the annual entomological inoculation rate were 2.71, 20.90, and 175.54 infectious bites PPY
inWalukuba, Kihihi, and Nagongera, respectively (Table 1). The primary vector species in
Walukuba was A. arabiensis, followed by A. gambiae s.s. and A. funestus. In Kihihi almost all
mosquitoes were A. gambiae s.s., and in Nagongera the primary vector was A. gambiae s.s., fol-
lowed by A. arabiensis and A. funestus (Table 1). Insecticide susceptibility testing was per-
formed usingWHO bioassays for available vector species from the study sites in 2014. Testing
of A. gambiae s.s. in Kihihi and Nagongera revealedmoderate to high resistance to DDT and
pyrethroids (deltamethrin and permethrin), lower resistance to bendiocarb, and full suscepti-
bility to organophosphates (fenitrothion and malathion). Testing of A. arabiensis inWalukuba
and Nagongera revealed low resistance to DDT (Walukuba only), high resistance to pyre-
throids, and full susceptibility to bendiocarb and organophosphates (Fig 2).
Coverage levels of key malaria control interventions were obtained from repeated cross-sec-
tional community surveys, routine assessments of cohort participants, and data from the Ugan-
dan NMCP. In 2012, the proportion of households with at least one LLIN ranged from 51.0%
in Kihihi to 78.5% in Nagongera, with slightly lower estimates in 2013. Considering the propor-
tion of households with at least one LLIN per two persons, coverage levels were relatively low
at all sites in 2012 and 2013 (range 17.0%–35.5%), consistent with a lack of sufficient numbers
Table 1. Summary statistics from longitudinal surveillance studies.
Data Source Metric Study Site
Walukuba Kihihi Nagongera
Health-facility-based surveillance Visits for children 0.5–10 y of age 42,833 28,790 38,690
Malaria suspected (percent of total) 23,529 (54.9%) 23,733 (82.4%) 31,847 (82.3%)
Laboratory testing done (percent of suspected) 23,245 (98.8%) 23,656 (99.6%) 31,410 (98.6%)
Tested positive for malaria (percent of tested) 6,141 (26.4%) 11,442 (48.4%) 12,209 (38.9%)
Cohort studies Number of children observed 340 380 361
Person-years of observation 903 1,221 1,134
Number of episodes of malaria 261 2,216 2,736
Incidence of malaria (new episodes per person-year) 0.29 1.81 2.41
Entomology surveys Number of households observed 117 107 107
Number of nights of collection 4,951 5,141 5,114
Total female Anopheles mosquitoes collected 4,377 17,657 133,579
Anopheles species
A. gambiae s.s. 34.1% 98.1% 67.5%
A. arabiensis 54.3% 0.6% 21.6%
A. funestus 5.3% 0.7% 10.1%
Other 6.4% 0.5% 0.8%
Daily human biting rate (mosquitoes per house-night) 0.88 3.43 26.12
Sporozoite rate1 0.84% 1.67% 1.84%
Annual entomological inoculation rate2 2.71 20.90 175.54
Data are given as number, number (percent), or percent, unless otherwise indicated.
1Number of mosquitoes testing positive for sporozoites/the number of mosquitoes tested.
2Daily human biting rate × sporozoite rate × 365 d/y.
doi:10.1371/journal.pmed.1002167.t001
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Fig 2. Insecticide susceptibility testing: 24-h mortality for A. gambiae s.s. (Kihihi and Nagongera only) and A.
arabiensis (Walukuba and Nagongera only) exposed for 1 h to insecticide-treated papers impregnated with WHO
diagnostic concentrations of insecticides. By WHO convention, mortality of 98%–100% indicates susceptibility, <98%
is suggestive of resistance, and <90% is strongly suggestive of resistance. Error bars give 95% standard errors.
doi:10.1371/journal.pmed.1002167.g002
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of LLINs even among households that owned at least one. According to data from the NMCP,
the number of LLINs distributed in our study sites ranged from 0.63 per person in Kihihi to
0.80 per person inWalukuba. In cross-sectional surveys conducted 10–17 mo following the
universal LLIN distribution campaigns, the proportion of households with at least one LLIN
increased from the prior surveymodestly in Walukuba (from 49.0% to 65.0%) and more sub-
stantially in Kihihi (from 37.5% to 86.5%) and Nagongera (from 71.0% to 95.5%). Considering
the proportion of households with at least one LLIN per two persons, increases from the prior
surveywere even greater at all sites (Walukuba 31.0% to 52.0%, Kihihi 19.0% to 73.0%, and
Nagongera 22.5% to 62.0%; Table 2). All cohort study participants and their family members
were provided LLINs at enrolment. Over 99% of children were reported to have slept under an
LLIN the prior evening at the time of routine visits. Government-supported IRS campaigns
were not conducted inWalukuba and Kihihi, and cross-sectional survey data revealed only a
few households that reported recent IRS use. In Nagongera, an IRS campaign was begun in
December 2014, with plans to spray with the carbamate bendiocarb every 6 mo. According to
data from the NMCP, over 95% of houses were sprayed during each of the three rounds. Data
from our cross-sectional survey conducted in January–February 2015 estimated that 78% of
houses received IRS, but this is likely an underestimate of the proportion of houses that were
Table 2. Coverage level of malaria control interventions.
Metric Time Period or Measure Study Site
Walukuba Kihihi Nagongera
LLIN coverage
Proportion of households with at least one LLIN1 20122 57.5% 51.0% 78.5%
20132 49.0% 37.5% 71.0%
20152 65.0% 86.5% 95.5%
Proportion of households with at least one LLIN per two persons1 20122 28.5% 17.0% 35.5%
20132 31.0% 19.0% 22.5%
20152 52.0% 73.0% 62.0%
Universal LLIN distribution campaign Date November
2013
June
2014
November 2013
Total population 29,020 54,443 38,867
Number of LLINs
distributed
23,456 34,420 27,120
IRS coverage
Proportion of households reporting IRS in the prior 12 mo1 20122 2.5% 0% 0%
20132 1.5% 0.5% 0%
20152 0% 0% 78.0%
Dates of community-wide IRS campaign (proportion of houses
sprayed)
1st round N/A N/A Dec 14–Feb 15
(96.9%)
2nd round N/A N/A Jun 15–Jul 15 (95.6%)
3rd round N/A N/A Nov 15–Dec 15
(96.8%)
ACT coverage
Proportion of malaria cases in the prior 2 wk that were given ACT1 20122 75.0% 82.1% 77.8%
20132 52.6% 75.0% 87.2%
20152 85.7% 91.7% 94.6%
1Data from cross-sectional surveys done in 200 households per study site per year.
2Surveys done each year January–February in Nagongera, March–April in Walukuba, and May–June in Kihihi.
ACT, artemisinin-based combination therapy; IRS, indoor residual spraying of insecticide; LLIN, long-lasting insecticidal net; N/A, not applicable.
doi:10.1371/journal.pmed.1002167.t002
Malaria Burden following Control Interventions in Uganda
PLOS Medicine | DOI:10.1371/journal.pmed.1002167 November 8, 2016 12 / 22
ultimately sprayed, as the first round of IRS was ongoing when this surveywas conducted
(Table 2). Among the households participating in the cohort study, over 94% received IRS dur-
ing each of the three rounds conducted in Nagongera. ACT coverage among children report-
edly treated for malaria from cross-sectional surveyswas 75% or higher across all three surveys
at all three sites, with the exception of Walukuba in 2013 (Table 2). Children in the cohort
studies received treatment with artemether-lumefantrine for all episodes of laboratory-con-
firmed uncomplicated malaria.
Temporal trends in monthly crude estimates of malaria metrics from the different study
sites are presented in Fig 3, and changes following universal LLIN distribution and IRS using
time-series analyses to adjust for secular trends are presented in Table 3. In Walukuba, the
Fig 3. Temporal trends in monthly estimates of malaria test positivity rate from health-facility-based surveillance, incidence of
malaria from cohort studies, and daily human biting rate from entomology surveys. Yellow vertical bars indicate when universal
distribution of long-lasting insecticidal nets occurred. Pink vertical bars indicate when each round of indoor residual spraying with
bendiocarb was implemented. Daily human biting rate is the number of female Anopheles mosquitoes captured per house-night of
collection. PPY, per person-year.
doi:10.1371/journal.pmed.1002167.g003
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lowest transmission site, malaria metrics were declining over the 26-mo period prior to univer-
sal distribution of LLINs. Over the 28-mo post-intervention period, universal LLIN distribu-
tion was associated with reductions in the TPR (aRR = 0.70, 95% CI 0.46–1.06, p = 0.09) and
HBR (aRR = 0.41, 95% CI 0.14–1.18, p = 0.10) that did not reach statistical significance and no
change in the incidence of malaria (aRR = 1.02, 95% CI 0.36–2.91, p = 0.97). In Kihihi, over the
21-mo post-intervention period, universal LLIN distribution was associated with a reduction
in the incidence of malaria (aRR = 0.65, 95% CI 0.43–0.98, p = 0.04) but no significant change
in the TPR (aRR = 0.83, 95% 0.58–1.18, p = 0.30) or HBR (aRR = 0.71, 95% CI 0.30–1.64,
p = 0.40). In Nagongera, the highest transmission site, over the 12-mo post-intervention period
prior to the implementation of IRS, universal LLIN distribution was associated with a reduc-
tion in the TPR (aRR = 0.82, 95% CI 0.76–0.88, p< 0.001) but no significant change in the inci-
dence of malaria (aRR = 1.10, 95% CI 0.76–1.59, p = 0.60) or HBR (aRR = 0.87, 95% CI 0.31–
2.47, p = 0.80). In contrast, compared to the 14-mo period following universal LLIN distribu-
tion, the added implementation of three rounds of IRS over a 14-mo period in Nagongera was
associated with marked reductions in the TPR (aRR = 0.54, 95% CI 0.49–0.60, p< 0.001), inci-
dence of malaria (aRR = 0.13, 95% CI 0.07–0.27, p< 0.001), and HBR (aRR = 0.29, 95% CI
0.17–0.50, p< 0.001).
This study provided the opportunity to evaluate relationships between temporal changes in
two complementary measures of malaria morbidity:malaria incidencemeasured in the cohort
studies and TPR measured by health-facility-based surveillance. Linear correlations between
relative monthly changes in the incidence of malaria observed in the cohort studies and pre-
dicted from the health-facility-based surveillanceTPRs are presented in S2 Fig. At all three
sites, there were significant positive correlations between these two measures, with correlation
coefficients ranging from 0.39 in Kihihi to 0.66 in Nagongera. The slopes for the lines of best fit
were<1 for all three sites, indicating that predictions from the TPRs tended to be lower than
observations from the cohort studies. The cumulative monthly relative changes in the inci-
dence of malaria observed in the cohort studies and predicted from the health-facility-based
surveillanceTPRs are presented in S3 Fig. These two measures tracked well over time and in
relation to the implementation of LLIN distribution and IRS, althoughmalaria incidence rela-
tive to baseline predicted from the TPRs tended to be lower than what was observed from the
cohort studies.
Discussion
We utilized a comprehensive malaria surveillance system in three sites in Uganda with varied
malaria epidemiology to measure changes in malaria metrics and mosquito exposure before
and after malaria control interventions were delivered under operational conditions at the pop-
ulation level. The primary intervention was a national universal LLIN distribution campaign,
with the goal of providing one LLIN for every two persons. The distribution campaign substan-
tially increased LLIN coverage levels, but did not reach the universal coverage target. LLIN dis-
tribution was associated with modest reductions in malaria TPRs at all three sites, but the
reduction reached statistical significance only in the highest transmission intensity site
(Nagongera). There was a reduction in the incidence of malaria only in the medium transmis-
sion site (Kihihi) and reductions in the HBR that did not reach statistical significance at any of
the sites. In contrast, in the highest transmission site (Nagongera), delivery of three rounds of
IRS with the carbamate bendiocarbwas associated with marked declines in all three malaria
metrics. Notably, we documented high-level pyrethroid resistance among A. gambiae s.s. and
A. arabiensis vectors across our study sites, which may have contributed to the limited changes
seen following the distribution of LLINs. Our results suggest that IRS with non-pyrethroid
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insecticides is currently the most effective intervention available for reducing the burden of
malaria in Uganda in areas where maximum bednet coverage is not obtained despite attempts
at universal distribution.
Insecticide-treatednets (ITNs), including LLINs, are the most widely used intervention for
the control of malaria in Africa, and universal coverage is recommended by WHO. The bene-
fits of ITNs have been well established in several randomized controlled trials, with use of ITNs
associated with a reduction in the incidence of malaria of 50% and a reduction in child mortal-
ity of 20% [5]. Analyses of observational data from cross-sectional surveys have suggested that
the protective efficacy of ITNs under operational settings is similar to that observed in con-
trolled trials [6]. Recently, using a large database of malaria field surveys, it was estimated that
the incidence of malaria decreased by 40% across sub-Saharan Africa between 2000 and 2015,
and that ITNs were responsible for 68% of cases averted [2]. Although these estimates are
encouraging, they are based on measurement of parasite prevalence and not disease incidence.
The relationship between parasite prevalence and the incidence of malaria remains uncertain,
and contemporary, high-quality longitudinal data to clarify the relationship between these
indicators are limited.
The scale-up of ITN coverage in Uganda (and many other countries in sub-Saharan Africa)
has been impressive. Based on national surveys, the proportion of households in Uganda
reporting ownership of at least one ITN increased from 16% in 2006 to 60% in 2011 following
a series of sub-national distribution campaigns, and then to 90% in 2014 following the univer-
sal LLIN distribution campaign [25–27]. The average number of ITNs per household increased
from 0.8 in 2009 to 2.5 in 2014 [27]. Although quality surveillancedata to estimate the impact
of the initial scale-up of ITN provision in Uganda are lacking, there is evidence from our study
of a decline in the burden of malaria preceding the universal LLIN campaign inWalukuba. It is
unclear what was responsible for this initial decline and why it was seen only inWalukuba,
although this may have been influenced by the lower level of transmission intensity and greater
urbanization inWalukuba compared to the other two sites [16,28].
Despite gradual improvements in the coverage levels of ITNs over the last 10 y in Uganda,
evidence from this study suggests that the universal LLIN distribution campaign was followed
by only modest declines in some malaria metrics at our three study sites. There are several
potential explanations for these disappointing results. Perhaps of greatest concern is the recent
emergence and spread of resistance to pyrethroids, the only class of insecticides available for
LLINs. We documented high-level pyrethroid resistance among A. gambiae s.s. and A. arabien-
sis vectors in our study sites, a trend that is occurring across Africa [29]. Estimating the role of
pyrethroid resistance in the protective efficacy of LLINs under operational conditions remains
a significant challenge. However, increases in malaria cases have been attributed to the emer-
gence of pyrethroid resistance in longitudinal studies from South Africa and Senegal [30,31].
Also of concern are putative changes in vector behavior and shifts in the relative abundance of
vector species, which may increase (or leave unchanged) exposure risk during the early evening
hours while people are outside of their bed nets and unprotected by LLINs [32,33]. In our
study, vector behavioral characteristics were not assessed, and although there were differences
in species composition between the three study sites, there was no evidence of a shift in species
composition over time at any of the sites. Finally, it is possible that the LLINs were indeed
effective, but that the lack of significant changes in malaria metrics was due to inadequate cov-
erage resulting from insufficient numbers of LLINs, loss of nets, or poor compliance. Even
after the LLIN distribution campaign, fully universal coverage levels were not achieved.We did
not assess LLIN durability and compliance, so we are unable to characterize the contributions
of these factors to the outcomes.
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Historically, IRS has played a major role in the elimination of malaria in several countries
outside of Africa and in greatly reducing the burden of malaria in parts of Africa with low or
seasonal transmission [9,34]. However, the evidence base from randomized controlled trials
for IRS efficacywhen used alone is limited [35]. A number of recent observational studies and
cluster randomized trials from Africa comparing the efficacy of IRS combined with ITNs ver-
sus either intervention alone have provided mixed results. In observational studies from Equa-
torial Guinea and Mozambique, IRS combined with ITNs was associated with a lower odds of
parasitemia measured in cross-sectional surveys compared to either intervention alone [36].
An analysis of cross-sectional survey data from 17 countries in sub-Saharan Africa indicated
that the combination of IRS and ITNs was associated with a lower risk of parasitemia com-
pared to either intervention alone in medium and high transmission areas [37]. In an observa-
tional study from western Kenya using a prospective cohort study design, the combination of
IRS and ITNs was associated with a lower incidence of new infection compared to ITNs alone
[38]. In another observational study from western Kenya, in a setting with high transmission
intensity and moderate ITN coverage, two rounds of IRS with pyrethroid insecticideswas asso-
ciated with a lower odds of parasitemia from cross-sectional surveys compared to ITNs alone
[39]. In contrast, observational studies from Eritrea and Burundi demonstrated a protective
effect of IRS and ITNs when used together, but failed to show any added benefit of the combi-
nation compared to either intervention alone [40,41].
Results from cluster randomized trials evaluating ITNs and IRS have also provided conflict-
ing findings. In a study from northwest Tanzania, in a setting with high levels of pyrethroid
resistance, 50 clusters received ITNs as part of a universal coverage campaign, and 25 clusters
were randomly assigned to additionally receive two rounds of IRS with bendiocarb. The addi-
tion of IRS was associated with a significant reduction in parasite prevalence in cross-sectional
surveys of children, and there was a non-significant tendency towards a lower entomological
inoculation rate [42]. Although reported ITN use was suboptimal in this trial, in subgroup
analyses ITNs provided some individual protection and IRS provided additional protection
among both net-users and non-users [8]. In contrast, two studies fromWest Africa failed to
show any additional benefit of IRS over ITNs alone. In a high transmission area of Beninwith
moderate pyrethroid resistance, the addition of IRS with bendiocarbor carbamate-treated plas-
tic sheeting to targeted or universal LLIN coverage did not provide benefit in reducing the inci-
dence of malaria or parasite prevalence in cohorts of children [43]. In a moderate transmission
area of the Gambia with susceptible vectors, the addition of IRS with DDT to a background of
high LLIN coverage did not provide any benefit in reducing the incidence of malaria, parasite
prevalence, or measures of transmission intensity [44]. The results of these studies and our new
findings suggest a pattern. Adding IRS to LLINs appears to be most effective in areas where
LLIN coverage is low and/or pyrethroid resistance is high. In addition, in areas where LLIN
coverage is high, IRS may be most effective when using non-pyrethroid-based insecticides, in
line with currentWHO recommendations, and as seen in our study.
There were several limitations to our study, and results should be interpreted with caution.
The main limitation was the use of an observational study design, comparing outcomes before
and after the interventions were implemented. Although we utilized a rigorous analytical
approach to adjust for secular trends, the lack of contemporaneous control groups limited our
ability to make rigorous causal inferences. In addition, the interventions were implemented
under programmatic conditions and not in the setting of a rigorous clinical trial. This is of par-
ticular relevance for estimates of changes in malaria metrics following the universal LLIN dis-
tribution campaign, which was preceded by other sub-national distribution campaigns. Also
these estimates do not include consideration of adherence or net quality. Because cohort partic-
ipants received LLINs at the start of the study, the cohort study and entomology survey data
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utilized in this study provided estimates of changes in malaria incidence and HBR following
universal LLIN distribution in the setting of existing LLIN ownership. In contrast, data from
the health-facility-based surveillancemeasured direct changes in malaria TPR following uni-
versal LLIN distribution. Thus, these measures are complementary. Despite these limitations,
our study benefitted from a comprehensive malaria surveillance system focusing on multiple
indicators measured longitudinally, including disease incidence, a major improvement com-
pared to cross-sectional surveysmeasuring only parasite prevalence.
Uganda is representative of several countries in sub-Saharan Africa that have made great
strides in reducing the burden of malaria but face substantial challenges on the road to elimina-
tion. LLINs and IRS remain the primary interventions for the prevention of malaria in Africa;
however, their relative roles in the setting of limited resources are controversial. Like most Afri-
can countries, Uganda has focused on maximizing coverage with LLINs. Over the last decade,
this has led to dramatic increases in coverage levels, culminating in a national universal LLIN
distribution campaign resulting in 90% of households owning at least one LLIN and 72% of
persons reportedly sleeping under an LLIN [27]. IRS has also become a key component of
Uganda’s malaria control strategy, but resource constraints have limited its use to selected
areas of the country, with less than 10% of the population protected by IRS, a level similar to
that in several other African countries [10]. In this study, following the recent universal LLIN
distribution campaign, we found evidence of a modest decline in the burden of malaria at one
relatively low transmission site (Walukuba), but no reduction in two higher transmission sites
(Kihihi and Nagongera). In contrast to the limited changes following LLIN distribution, three
rounds of IRS with a carbamate insecticide at one high transmission site (Nagongera) was fol-
lowed by a marked decline in the burden of malaria. These data strongly suggest that IRS with
non-pyrethroid-based insecticides in combination with LLINs is the most effective interven-
tion currently available for reducing the burden of malaria in Uganda. Resources are needed to
increase LLIN coverage and expand the IRS program to cover a greater proportion of the
Ugandan population. Given the complex and dynamic nature of vector populations, insecticide
resistance patterns, local epidemiology, and the operational effectiveness of malaria control
interventions, it is not possible to develop a “one size fits all” approach to malaria control in
Africa.More resources are needed to support high-quality malaria surveillance to assess the
effectiveness of malaria control interventions over time and space to support evidence-based
policy decisionmaking.
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